By Our Correspondent
BHUBANESWAR: This is to inform you that intranasal vaccine – iNCOVACC is available for use in private sector under Covid-19 vaccination programme the technical details of which are as follows:
Vaccine name: iNCOVACC
Manufacturer Name: Bharat Biotech (BBIL)
Vaccine type: Intranasal
Vaccine description (Type): Covid-19 Vaccine, Intranasal Recombinant (Adenovirus Vector based)
Dose per vial: Two doses
Eligible Beneficiaries 18 years and above,
1. 18 Yrs and above for Primary Vaccination and third dose (Precaution Dose)
2. Heterologous precaution dose for people of 18 years and above, after 6 months of primary vaccination (two doses) of Covaxin or Covishield.
Doses per beneficiary: 0.5ml per dose in 8 drops,(4 drops in each nostril)
No. of Doses: Two doses for primary schedule
Dose Frequency: 28 days apart (Primary schedule)
The necessary changes on Co-WIN platform for same are being made.
